SK Bioscience Co Ltd (302440) — Net Asset Momentum
SK Bioscience Co Ltd (302440) recorded a net asset momentum of 18.7% as of December 2024, with net assets of ₩2.02 Trillion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See net assets of SK Bioscience Co Ltd for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
SK Bioscience Co Ltd Net Asset Momentum (2018–2024)
This chart tracks SK Bioscience Co Ltd's year-over-year net asset growth across 7 annual reporting periods from 2018 to 2024. The most recent momentum reading is +18.7%, with net assets of ₩2.02 Trillion KRW as of December 2024. For live market cap and overall valuation, see SK Bioscience Co Ltd market capitalisation.
Annual Net Asset History for SK Bioscience Co Ltd (2018–2024)
The table below shows the complete annual net asset history for SK Bioscience Co Ltd from 2018 to 2024, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check 302440 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ₩2.02 Trillion | ₩2.84 Trillion | ₩821.14 Billion | ▲ +18.7% |
| 2023 | ₩1.70 Trillion | ₩1.85 Trillion | ₩148.58 Billion | ▼ -2.2% |
| 2022 | ₩1.74 Trillion | ₩2.14 Trillion | ₩400.23 Billion | ▲ +8.8% |
| 2021 | ₩1.60 Trillion | ₩2.11 Trillion | ₩508.81 Billion | ▲ +507.0% |
| 2020 | ₩263.79 Billion | ₩562.23 Billion | ₩298.44 Billion | ▲ +13.3% |
| 2019 | ₩232.73 Billion | ₩403.98 Billion | ₩171.25 Billion | ▲ +10.4% |
| 2018 | ₩210.73 Billion | ₩402.71 Billion | ₩191.98 Billion | — |